Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis-Reference-Cited by-同舟云学术

Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis

Published:2019-05-27 Issue:2 Volume:84 Page:373-382
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Pétain Aurélie,Zhong Dafang,Chen Xiaoyan,Li Zhang,Zhimin Shao,Zefei Jiang,Zorza Grégoire,Ferré Pierre^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-019-03872-9.pdf

Reference24 articles.

1. Pierre Fabre Press Release (2014, Sept 24) Pierre Fabre Médicament obtains MA in China for NAVELBINE® Oral (Vinorelbine) in the treatment of advanced lung and breast cancer. https://www.pierre-fabre.com/en/news/pierre-fabre-medicament-obtains-ma-in-china-for-navelbineroral-vinorelbine

2. Johansen M, Kuttesch J, Bleyer WA et al (2006) Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children’s Oncology Group. Clin Cancer Res 12(2):516–522

3. Schilling T, Fiebig HH, Kerpel-Fronius S et al (1996) Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients. Invest New Drugs 14(4):371–378

4. Jassem J, Ramlau R, Karnicka-Mlodkowska H et al (2001) A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients. Ann Oncol 12(10):1375–1381

5. Leveque D, Jehl F (1996) Clinical pharmacokinetics of vinorelbine. Clin Pharmacokinet 31(3):184–197

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in antitumor activity and mechanism of natural steroidal saponins: A review of advances, challenges, and future prospects;Phytomedicine;2024-06

2. Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-arm, Prospective Study;Cancer Research and Treatment;2023-10-12

3. Practical Application of PK/TK Models: Population Pharmacokinetics/Toxicokinetics;Handbook of Pharmacokinetics and Toxicokinetics;2023-07-03

4. Cardiotoxic Effects of Yew Tree and Pink Periwinkle Alkaloids;Safety and Risk of Pharmacotherapy;2021-11-08

5. Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer;Women's Health Reports;2020-04-01